Report Open Access

Modelled public health impact and cost effectiveness estimates of RTS,S/AS01 malaria vaccine in perennial and seasonal settings (August 2021)

Swiss TPH; PATH; Imperial College; London School of Hygiene & Tropical Medicine

Reports considered by the Strategic Advisory Group of Experts on Immunization (SAGE) and the Malaria Policy Advisory Group (MPAG) for the development of the malaria vaccine recommendation, “Section 4.3 Vaccine” of the WHO Guidelines for malaria, originally published 18 February 2022.

Files (3.0 MB)
Name Size
Modelled-public-health-impact-and-cost-effectiveness-rtss-vaccine-2021.pdf
md5:7399ec680c7f45a58345054d7fb5d6cc
3.0 MB Download
155
38
views
downloads
All versions This version
Views 155155
Downloads 3838
Data volume 114.4 MB114.4 MB
Unique views 152152
Unique downloads 3636

Share

Cite as